TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 26 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $704,000 | -6.5% | 2,288,560 | 0.0% | 0.02% | +21.4% |
| Q2 2019 | $753,000 | -50.1% | 2,288,560 | 0.0% | 0.01% | -65.0% |
| Q1 2019 | $1,510,000 | -61.4% | 2,288,560 | 0.0% | 0.04% | -69.2% |
| Q4 2018 | $3,913,000 | -70.5% | 2,288,560 | 0.0% | 0.13% | -60.4% |
| Q3 2018 | $13,274,000 | -3.3% | 2,288,560 | 0.0% | 0.33% | -15.9% |
| Q2 2018 | $13,731,000 | -15.3% | 2,288,560 | +1.6% | 0.39% | -30.9% |
| Q1 2018 | $16,214,000 | +2.9% | 2,252,006 | +3.6% | 0.56% | +0.2% |
| Q4 2017 | $15,754,000 | – | 2,173,000 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|